Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular EventsMarc S. Sabatine, Evan A. Stein, Robert P. Giugliano et al.|New England Journal of Medicine|2015Cited by 1.5k
Simvastatin with or without Ezetimibe in Familial HypercholesterolemiaJohn J.P. Kastelein, Eric de Groot, Raphaël Duivenvoorden et al.|New England Journal of Medicine|2008Cited by 1.2k
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialFrederick J. Raal, Daniel Gaudet, Evan A. Stein et al.|The Lancet|2014Cited by 750
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trialEvan A. Stein, Robert Pordy, Dan Gipe et al.|The Lancet|2012Cited by 579
THE RELATION OF DIET, CIGARETTE SMOKING, AND ALCOHOL CONSUMPTION TO PLASMA BETA-CAROTENE AND ALPHA-TOCOPHEROL LEVELSW. SCOTT STRYKER, Walter C. Willett, Lawrence A. Kaplan et al.|American Journal of Epidemiology|1988Cited by 519